CymitQuimica logo

Abiraterone - Bio-X ™

CAS:

Ref. 3D-BA164060

10mg
135.00€
Abiraterone - Bio-X ™
Biosynth

Product Information

Name:Abiraterone - Bio-X ™
Controlled Product
Synonyms:
  • CB 7598(3b)-17-(3-Pyridinyl)androsta-5,16-dien-3-ol
Brand:Biosynth
Description:Abiraterone is an anti-cancer drug that has been shown to be effective in treating prostate cancer. It works by blocking the production of testosterone by inhibiting androgen synthesis. Abiraterone does this by inhibiting CYP17A1, which converts cholesterol into pregnenolone, and then into progesterone and testosterone. Furthermore, it binds to the enzyme steroid 5-alpha reductase, which converts testosterone into dihydrotestosterone (DHT). Abiraterone is usually a last resort for patients who have stopped responding to other lines of hormone therapies, which is known as second-line therapy.
Notice:Our products are intended for lab use only. For any other use, please contact us.

Chemical properties

Molecular weight:349.51 g/mol
Formula:C24H31NO
Purity:Min. 95%
Color/Form:Powder
InChI:InChI=1S/C24H31NO/c1-23-11-9-18(26)14-17(23)5-6-19-21-8-7-20(16-4-3-13-25-15-16)24(21,2)12-10-22(19)23/h3-5,7,13,15,18-19,21-22,26H,6,8-12,14H2,1-2H3/t18-,19-,21-,22-,23-,24+/m0/s1
InChI key:InChIKey=GZOSMCIZMLWJML-VJLLXTKPSA-N
SMILES:C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@@]43C)[C@@H]1CC=C2c1cccnc1

Technical inquiry about: Abiraterone - Bio-X ™

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
◻️
CYMIT QUÍMICA, S.L. as responsible for the treatment will treat your data in order to respond to your queries or requests. You can access, rectify and delete your data, as well as exercise other rights by consulting the additional and detailed information on data protection in our Web Privacy Policy.
* Mandatory fields.